ZW6790A1 - Chemical compounds - Google Patents
Chemical compoundsInfo
- Publication number
- ZW6790A1 ZW6790A1 ZW67/90A ZW6790A ZW6790A1 ZW 6790 A1 ZW6790 A1 ZW 6790A1 ZW 67/90 A ZW67/90 A ZW 67/90A ZW 6790 A ZW6790 A ZW 6790A ZW 6790 A1 ZW6790 A1 ZW 6790A1
- Authority
- ZW
- Zimbabwe
- Prior art keywords
- chemical compounds
- compounds
- 10alkyl
- obesity
- intermediates
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
- C07C235/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898910374A GB8910374D0 (en) | 1989-05-05 | 1989-05-05 | Chemical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZW6790A1 true ZW6790A1 (en) | 1991-02-27 |
Family
ID=10656286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZW67/90A ZW6790A1 (en) | 1989-05-05 | 1990-04-30 | Chemical compounds |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0426804B1 (fr) |
| JP (1) | JPH03506037A (fr) |
| KR (1) | KR920701123A (fr) |
| CN (1) | CN1047857A (fr) |
| AT (1) | ATE100439T1 (fr) |
| AU (1) | AU622027B2 (fr) |
| BG (1) | BG93509A (fr) |
| CA (1) | CA2015705A1 (fr) |
| DD (1) | DD300542A5 (fr) |
| DE (1) | DE69006178T2 (fr) |
| DK (1) | DK0426804T3 (fr) |
| ES (1) | ES2062526T3 (fr) |
| FI (1) | FI910059A0 (fr) |
| GB (2) | GB8910374D0 (fr) |
| GR (1) | GR1001610B (fr) |
| HU (1) | HUT58277A (fr) |
| IE (1) | IE63533B1 (fr) |
| MW (1) | MW4190A1 (fr) |
| NO (1) | NO910033L (fr) |
| NZ (1) | NZ233425A (fr) |
| PL (1) | PL285062A1 (fr) |
| PT (1) | PT93954A (fr) |
| WO (1) | WO1990013535A1 (fr) |
| ZA (1) | ZA903111B (fr) |
| ZW (1) | ZW6790A1 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9111425D0 (en) * | 1991-05-28 | 1991-07-17 | Ici Plc | Chemical compounds |
| US5502078A (en) * | 1991-05-28 | 1996-03-26 | Zeneca Limited | Chemical compounds |
| GB9111426D0 (en) | 1991-05-28 | 1991-07-17 | Ici Plc | Chemical compounds |
| NO179246C (no) * | 1991-11-20 | 1996-09-04 | Sankyo Co | Aromatiske amino-alkoholderivater og mellomprodukter til fremstilling derav |
| GB9207964D0 (en) * | 1992-04-10 | 1992-05-27 | Ici Plc | Chemical compounds |
| US5563171A (en) * | 1993-11-05 | 1996-10-08 | American Cyanamid Company | Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists |
| US5578638A (en) * | 1993-11-05 | 1996-11-26 | American Cyanamid Company | Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US463323A (en) * | 1891-11-17 | Temporary binder | ||
| GB1245148A (en) * | 1968-11-18 | 1971-09-08 | Pfizer Ltd | Propanolamine derivatives |
| US4263323A (en) * | 1976-10-07 | 1981-04-21 | Aktiebolaget Hassle | β-Receptor blocking compounds and treatment of cardiovascular disorders therewith |
| DE3271132D1 (en) * | 1981-07-11 | 1986-06-19 | Beecham Group Plc | Secondary phenylethanol amines, processes for their preparation and their pharmaceutical application |
| GB8519154D0 (en) * | 1985-07-30 | 1985-09-04 | Ici Plc | Aromatic ethers |
-
1989
- 1989-05-05 GB GB898910374A patent/GB8910374D0/en active Pending
-
1990
- 1990-04-20 GB GB909008867A patent/GB9008867D0/en active Pending
- 1990-04-23 IE IE143890A patent/IE63533B1/en not_active IP Right Cessation
- 1990-04-24 ZA ZA903111A patent/ZA903111B/xx unknown
- 1990-04-24 NZ NZ233425A patent/NZ233425A/en unknown
- 1990-04-26 MW MW41/90A patent/MW4190A1/xx unknown
- 1990-04-30 DE DE90907243T patent/DE69006178T2/de not_active Expired - Fee Related
- 1990-04-30 ZW ZW67/90A patent/ZW6790A1/xx unknown
- 1990-04-30 WO PCT/GB1990/000668 patent/WO1990013535A1/fr not_active Ceased
- 1990-04-30 DK DK90907243.1T patent/DK0426804T3/da active
- 1990-04-30 HU HU903384A patent/HUT58277A/hu unknown
- 1990-04-30 KR KR1019910700017A patent/KR920701123A/ko not_active Withdrawn
- 1990-04-30 AT AT90907243T patent/ATE100439T1/de not_active IP Right Cessation
- 1990-04-30 FI FI910059A patent/FI910059A0/fi not_active Application Discontinuation
- 1990-04-30 CA CA002015705A patent/CA2015705A1/fr not_active Abandoned
- 1990-04-30 EP EP90907243A patent/EP0426804B1/fr not_active Expired - Lifetime
- 1990-04-30 ES ES90907243T patent/ES2062526T3/es not_active Expired - Lifetime
- 1990-04-30 AU AU55403/90A patent/AU622027B2/en not_active Ceased
- 1990-04-30 JP JP2506670A patent/JPH03506037A/ja active Pending
- 1990-05-04 GR GR900100332A patent/GR1001610B/el unknown
- 1990-05-04 PT PT93954A patent/PT93954A/pt not_active Application Discontinuation
- 1990-05-04 DD DD340389A patent/DD300542A5/de unknown
- 1990-05-04 PL PL28506290A patent/PL285062A1/xx unknown
- 1990-05-05 CN CN90102708A patent/CN1047857A/zh active Pending
- 1990-12-21 BG BG093509A patent/BG93509A/bg unknown
-
1991
- 1991-01-04 NO NO91910033A patent/NO910033L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0426804A1 (fr) | 1991-05-15 |
| BG93509A (bg) | 1993-12-24 |
| JPH03506037A (ja) | 1991-12-26 |
| GR900100332A (en) | 1991-10-10 |
| PL285062A1 (en) | 1992-01-13 |
| GB9008867D0 (en) | 1990-06-20 |
| MW4190A1 (en) | 1991-03-13 |
| NO910033L (no) | 1991-03-04 |
| DD300542A5 (de) | 1992-06-17 |
| ES2062526T3 (es) | 1994-12-16 |
| NZ233425A (en) | 1992-07-28 |
| FI910059A7 (fi) | 1991-01-04 |
| HUT58277A (en) | 1992-02-28 |
| CN1047857A (zh) | 1990-12-19 |
| PT93954A (pt) | 1991-01-08 |
| FI910059A0 (fi) | 1991-01-04 |
| AU622027B2 (en) | 1992-03-26 |
| WO1990013535A1 (fr) | 1990-11-15 |
| EP0426804B1 (fr) | 1994-01-19 |
| AU5540390A (en) | 1990-11-29 |
| KR920701123A (ko) | 1992-08-11 |
| NO910033D0 (no) | 1991-01-04 |
| DE69006178T2 (de) | 1994-05-05 |
| CA2015705A1 (fr) | 1990-11-05 |
| IE901438L (en) | 1990-11-05 |
| GR1001610B (el) | 1994-07-29 |
| ZA903111B (en) | 1991-12-24 |
| GB8910374D0 (en) | 1989-06-21 |
| IE63533B1 (en) | 1995-05-03 |
| DK0426804T3 (da) | 1994-05-30 |
| HU903384D0 (en) | 1991-05-28 |
| ATE100439T1 (de) | 1994-02-15 |
| DE69006178D1 (de) | 1994-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE881269L (en) | Steroids | |
| AU636738B2 (en) | Nematicidal compositions | |
| GR3017996T3 (en) | 17-g(b)-SUBSTITUTED-4-AZA-5-g(a)-ANDROSTAN-3-ONE DERIVATIVES AND PROCESS FOR THEIR PREPARATION. | |
| ZA857270B (en) | Tetralin derivatives,their preparation and their use | |
| AU7095587A (en) | 1,4-diazepines | |
| GB8910374D0 (en) | Chemical compounds | |
| EP0136647A3 (en) | Cyclohexenon derivatives, process for their preparation and their use in combating undesirable plant growth | |
| GR862247B (en) | Novel pyrrolo-benzimidazole pyrrolo-benzoxazole and pyrrolo-benzthiazole process for their preparation and medicaments containing said compounds | |
| GB8925032D0 (en) | Chemical compounds | |
| IL89628A0 (en) | Guanidinium compounds and their use as fungicides | |
| HUT71513A (en) | 2-substituted-(3-chlorophenyl)-3,6-diazahexanoic acid derivatives for producing alkil-trazodone derivatives and process for producing them | |
| ES2002207A6 (es) | Un metodo para producir derivados de glucosilmoranolina | |
| AU584098B2 (en) | Substituted azabicycloheptanes, the use thereof, pharmaceutical preparations that contain these compounds, and processes for the manufacture of these compounds | |
| AU586724B2 (en) | 1-phenyl-3-benzazepines | |
| SE8206548L (sv) | Bensylidenderivat | |
| AU4610689A (en) | Pyridine-3-peroxycarboxylic acid monopersulfate | |
| EP0276805A3 (en) | Substituted 3-phenyl-7h-thiazoloû3,2-b¨û1,2,4¨triazin-7-ones, processes for their preparation, medicaments containing them and their use as well as some of the intermediates obtained during the preparation of said compounds | |
| EP0194164A3 (en) | N-carboxyalcoyl-2-oxo-3-diaryl-5,6-triazines useful as therapeutic agents | |
| HU905000D0 (en) | Process for producing compounds suitable for treatment of gastric ulcer | |
| GR850484B (fr) | ||
| EP0292820A3 (en) | 3-phenyl-2-styryl-pyrrolidines, their preparation and use |